New diabetes clinical trial: Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria

Published on: 2026-09-30T04:00:00Z
Conditions: Obesity; Chronic Kidney Disease; Albuminuria
Interventions: Drug: Finerenone; Drug: Finerenone Placebo; Drug: Semaglutide
Sponsors: Peking University People's Hospital; Daqing Oil Field Hospital; First Affiliated Hospital Xi'an Jiaotong University; The Second Affiliated Hospital of Qiqihar Medical University; Capital Medical University; Huai'an Fifth People's Hospital; Heilongjiang Provicial Hospital; The First Affiliated Hospital of Henan University of Science and Technology; Shenzhen University General Hospital; Qiqihar First People's Hospital; Zibo Central Hospital; Hebei General Hospital; Suzhou Municipal Hospital; Yan'an University Affiliated Hospital; Tianjin People's Hospital; The First Hospital of Hebei Medical University; Daqing Longnan Hospital; Bayer Healthcare Co., Ltd.; Luoyang First People's Hospital; Beijing Pinggu District Hospital
Not yet recruiting
https://ift.tt/VmnhbNk